Colitis, Ulcerative: all 1,530 studies

Page 5 of 16. Open to participants first (407), then studies with results posted, then the rest; newest registration first within each.

• Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)RecruitingNCT02421705Not applicable
• The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)RecruitingNCT02308917
• Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative ColitisRecruitingNCT01882205Not applicable
• Standardized Fecal Microbiota Transplantation for Ulcerative ColitisRecruitingNCT01790061Phase 2/3
• Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.RecruitingNCT01731665
• Gene Expression in Inflammatory Bowel DiseaseEnrolling by invitationNCT01171872
• Immune Regulation in Ulcerative Colitis or Crohn s DiseaseRecruitingNCT00001184
• Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UCCompletedNCT06591013Not applicableResults posted
• Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal AnastomosisCompletedNCT06316999Not applicableResults posted
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)TerminatedNCT06137183Phase 2Results posted
• A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisCompletedNCT05796245Results posted
• Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative ColitisTerminatedNCT05785715Phase 2Results posted
• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT05767021Phase 3Results posted
• A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative ColitisActive, not recruitingNCT05739162Not applicableResults posted
• A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel DiseaseCompletedNCT05651542Not applicableResults posted
• A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UCCompletedNCT05611671Phase 2Results posted
• Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative ColitisCompletedNCT05570006Phase 2Results posted
• A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT05528510Phase 3Results posted
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2CompletedNCT05507216Phase 3Results posted
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1CompletedNCT05507203Phase 3Results posted
• A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseCompletedNCT05499130Phase 2Results posted
• A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in RemissionTerminatedNCT05479058Phase 3Results posted
• An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical PracticeTerminatedNCT05369832Phase 4Results posted
• A Phase 2a Open-Label Study to Evaluate the Efficacy and Safety of MORF-057 in Adults With UCCompletedNCT05291689Phase 2Results posted
• The Impact of Circadian Misalignment on Colonic Barrier Homeostasis in Ulcerative ColitisCompletedNCT05180279Not applicableResults posted
• VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative ColitisTerminatedNCT05156125Phase 2Results posted
• A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy ParticipantsCompletedNCT05131971Phase 1Results posted
• This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.CompletedNCT05082428Results posted
• Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.TerminatedNCT05069259Results posted
• Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT05061446Phase 2Results posted
• Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative ColitisTerminatedNCT05019742Phase 2Results posted
• A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)CompletedNCT04996797Phase 2Results posted
• Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative ColitisTerminatedNCT04987307Phase 2Results posted
• A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)CompletedNCT04924114Phase 1Results posted
• Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative ColitisCompletedNCT04882007Phase 2Results posted
• A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative ColitisCompletedNCT04877990Phase 2Results posted
• A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)CompletedNCT04873700Results posted
• Digital Behavioral Interventions in Inflammatory Bowel DiseaseCompletedNCT04861597Not applicableResults posted
• GI Permeability Change in Response to Aquamin®CompletedNCT04855799Phase 2Results posted
• Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)CompletedNCT04852666Results posted
• A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's DiseaseCompletedNCT04804540Phase 4Results posted
• A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)CompletedNCT04779307Phase 3Results posted
• A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive, not recruitingNCT04738942Phase 3Results posted
• Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)CompletedNCT04706793Phase 3Results posted
• A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)CompletedNCT04700449Phase 2Results posted
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)TerminatedNCT04677179Phase 2Results posted
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)CompletedNCT04630028Phase 3Results posted
• A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT04613518Phase 2Results posted
• Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative ColitisCompletedNCT04607837Phase 2Results posted
• Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative ColitisCompletedNCT04596293Phase 2Results posted
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative ColitisCompletedNCT04577794Phase 2Results posted
• Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical OutcomesCompletedNCT04567628Results posted
• A Study With GB004 in Adult Subjects With Active Ulcerative Colitis (UC)TerminatedNCT04556383Phase 2Results posted
• Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative ColitisCompletedNCT04505410Phase 3Results posted
• Open-label Extension Study of Brazikumab in Ulcerative ColitisTerminatedNCT04277546Phase 2Results posted
• Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, JordanCompletedNCT04223479Phase 2/3Results posted
• CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)CompletedNCT04205643Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative ColitisTerminatedNCT04130919Phase 2Results posted
• Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative ColitisTerminatedNCT04074590Phase 2Results posted
• Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis PatientsCompletedNCT04071405Results posted
• ENhanced Recovery in CHildren Undergoing SurgeryCompletedNCT04060303Phase 3Results posted
• A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT04033445Phase 2/3Results posted
• Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving AsacolTerminatedNCT04032652Phase 2Results posted
• Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT04023396Phase 2Results posted
• A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)CompletedNCT04004611Phase 2Results posted
• Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative ColitisCompletedNCT03998488Phase 2Results posted
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative ColitisCompletedNCT03996369Phase 3Results posted
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative ColitisCompletedNCT03945188Phase 3Results posted
• Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)TerminatedNCT03943550Phase 1Results posted
• Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT03934216Phase 2Results posted
• TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) StudyTerminatedNCT03920254Phase 2/3Results posted
• Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative ColitisTerminatedNCT03893565Phase 2Results posted
• Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)CompletedNCT03884439Results posted
• Efficacy and Safety of Oral BT-11 in Ulcerative ColitisCompletedNCT03861143Phase 2Results posted
• ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDICompletedNCT03829475Phase 2Results posted
• Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]CompletedNCT03824561Results posted
• Efficacy and Safety of BBT-401-1S in Ulcerative ColitisTerminatedNCT03800420Phase 2Results posted
• Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative ColitisCompletedNCT03760003Phase 2Results posted
• A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative ColitisTerminatedNCT03759041Phase 2Results posted
• Efficacy & Safety of TD-1473 in Ulcerative ColitisTerminatedNCT03758443Phase 2/3Results posted
• A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) ParticipantsCompletedNCT03710486Results posted
• A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior TherapyCompletedNCT03695185Phase 2Results posted
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.CompletedNCT03675477Phase 2Results posted
• A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03662542Phase 2Results posted
• A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03653026Phase 3Results posted
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseTerminatedNCT03650413Phase 2Results posted
• BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative ColitisCompletedNCT03648541Phase 2Results posted
• Xeljanz Special Investigation for Long-term Use in UC PatientsCompletedNCT03643211Results posted
• Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative ColitisTerminatedNCT03616821Phase 2Results posted
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT03596645Phase 3Results posted
• Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on TofacitinibTerminatedNCT03591770Phase 4Results posted
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)CompletedNCT03558152Phase 2Results posted
• A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean ParticipantsCompletedNCT03535649Results posted
• A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life PracticeCompletedNCT03532932Results posted
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03524092Phase 3Results posted
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)CompletedNCT03518086Phase 3Results posted
• A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)CompletedNCT03488030Results posted
• BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative ColitisCompletedNCT03482635Phase 2/3Results posted
• A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's DiseaseTerminatedNCT03478956Phase 1Results posted
• A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03398148Phase 2/3Results posted

← Colitis, Ulcerative overview